M. Tevfik Dorak

3.5k total citations
73 papers, 2.4k citations indexed

About

M. Tevfik Dorak is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, M. Tevfik Dorak has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 15 papers in Public Health, Environmental and Occupational Health and 14 papers in Hematology. Recurrent topics in M. Tevfik Dorak's work include Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (18 papers) and Acute Lymphoblastic Leukemia research (14 papers). M. Tevfik Dorak is often cited by papers focused on Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (18 papers) and Acute Lymphoblastic Leukemia research (14 papers). M. Tevfik Dorak collaborates with scholars based in United States, United Kingdom and Canada. M. Tevfik Dorak's co-authors include Ebru Karpuzoglu, Alan K. Burnett, Mark Worwood, Ken Mills, Helmut K.G. Machulla, Richard A. Kaslow, Jianming Tang, Amy E. Kennedy, Elena Lobashevsky and Louise Parker and has published in prestigious journals such as The Lancet, Blood and American Journal of Epidemiology.

In The Last Decade

M. Tevfik Dorak

72 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Tevfik Dorak United States 26 696 520 382 377 342 73 2.4k
Andrew A. Adjei Ghana 32 508 0.7× 443 0.9× 660 1.7× 317 0.8× 234 0.7× 126 3.0k
Thomas Stallmach Switzerland 32 602 0.9× 873 1.7× 302 0.8× 342 0.9× 414 1.2× 100 3.7k
G.M.P. Galbraith United States 27 848 1.2× 569 1.1× 343 0.9× 195 0.5× 174 0.5× 98 2.4k
Peter G. Middleton United Kingdom 36 1.1k 1.6× 880 1.7× 316 0.8× 247 0.7× 934 2.7× 141 4.2k
Judith A. Smith United States 32 1.3k 1.9× 846 1.6× 349 0.9× 227 0.6× 728 2.1× 77 3.4k
Simone Kashima Brazil 26 498 0.7× 596 1.1× 270 0.7× 207 0.5× 192 0.6× 179 2.3k
R. Clark Brown United States 28 322 0.5× 603 1.2× 175 0.5× 181 0.5× 580 1.7× 104 2.5k
Issarang Nuchprayoon Thailand 24 298 0.4× 679 1.3× 195 0.5× 203 0.5× 571 1.7× 67 2.2k
C Cooper United States 23 607 0.9× 315 0.6× 220 0.6× 205 0.5× 210 0.6× 80 2.0k
Maurice R.G. O’Gorman United States 31 880 1.3× 592 1.1× 170 0.4× 258 0.7× 331 1.0× 104 2.7k

Countries citing papers authored by M. Tevfik Dorak

Since Specialization
Citations

This map shows the geographic impact of M. Tevfik Dorak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tevfik Dorak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tevfik Dorak more than expected).

Fields of papers citing papers by M. Tevfik Dorak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Tevfik Dorak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tevfik Dorak. The network helps show where M. Tevfik Dorak may publish in the future.

Co-authorship network of co-authors of M. Tevfik Dorak

This figure shows the co-authorship network connecting the top 25 collaborators of M. Tevfik Dorak. A scholar is included among the top collaborators of M. Tevfik Dorak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Tevfik Dorak. M. Tevfik Dorak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Brien, Mary Claire, et al.. (2022). Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity: are real-world studies the way forward?. Journal of Oncology Pharmacy Practice. 29(3). 646–662. 6 indexed citations
2.
Dorak, M. Tevfik, et al.. (2021). Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology. Oncology Reviews. 15(1). 510–510. 2 indexed citations
3.
Singh, Sandeep K. & M. Tevfik Dorak. (2017). Cancer Immunoprevention and Public Health. Frontiers in Public Health. 5. 101–101. 10 indexed citations
4.
Ezzat, Sameera, Wafaa M. Rashed, M. Tevfik Dorak, et al.. (2016). Environmental, maternal, and reproductive risk factors for childhood acute lymphoblastic leukemia in Egypt: a case-control study. BMC Cancer. 16(1). 662–662. 13 indexed citations
5.
Dorak, M. Tevfik, Michele R. Forman, Michael E. Scheurer, et al.. (2015). Evaluating the Role of Birth Weight and Gestational Age on Acute Lymphoblastic Leukemia Risk Among Those of Hispanic Ethnicity. Pediatric Hematology and Oncology. 32(6). 382–389. 9 indexed citations
6.
Kennedy, Amy E., Kala Y. Kamdar, Philip J. Lupo, et al.. (2014). Examination of HFE associations with childhood leukemia risk and extension to other iron regulatory genes. Leukemia Research. 38(9). 1055–1060. 17 indexed citations
7.
Dorak, M. Tevfik, et al.. (2010). Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. Molecular Human Reproduction. 16(10). 770–777. 8 indexed citations
8.
Dorak, M. Tevfik, et al.. (2009). Hereditary hemochromatosis gene (HFE) variants are associated with birth weight and childhood leukemia risk. Pediatric Blood & Cancer. 53(7). 1242–1248. 18 indexed citations
9.
Dorak, M. Tevfik, et al.. (2009). An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(2). 292–300. 41 indexed citations
10.
Dorak, M. Tevfik, et al.. (2009). A study of natural killer cell lectin‐like receptor K1 gene (KLRK1/NKG2D) region polymorphisms in a European population sample. Tissue Antigens. 73(2). 177–183. 4 indexed citations
11.
Dorak, M. Tevfik. (2007). Role of Natural Killer Cells and Killer Immunoglobulin-Like Receptor Polymorphisms. Methods in molecular medicine. 134. 123–144. 6 indexed citations
12.
Dorak, M. Tevfik, Mark S. Pearce, Donna M. Hammal, Richard McNally, & Louise Parker. (2007). Examination of gender effect in birth weight and miscarriage associations with childhood cancer (United Kingdom). Cancer Causes & Control. 18(2). 219–228. 27 indexed citations
13.
Lazaryan, Aleksandr, M. Tevfik Dorak, Ana Penman‐Aguilar, et al.. (2006). Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression. AIDS. 20(12). 1583–1590. 5 indexed citations
14.
Dorak, M. Tevfik, Jianming Tang, Ana Penman‐Aguilar, et al.. (2004). Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. The Lancet. 363(9427). 2137–2139. 44 indexed citations
15.
Sabek, Omaima M., M. Tevfik Dorak, Malak Kotb, A. Osama Gaber, & Lillian W. Gaber. (2002). Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation1. Transplantation. 74(5). 701–707. 77 indexed citations
16.
Dorak, M. Tevfik, Tom Lawson, Helmut K.G. Machulla, Ken Mills, & Alan K. Burnett. (2002). Increased heterozygosity for MHC class II lineages in newborn males. Genes and Immunity. 3(5). 263–269. 30 indexed citations
17.
Worwood, Mark, M. Tevfik Dorak, Stuart A. Nicklin, et al.. (1996). The frequency of the haemochromatosis‐associated genotype D6S265‐1:D6S105‐8 in blood donors. British Journal of Haematology. 93(4). 838–840. 8 indexed citations
18.
Dorak, M. Tevfik, et al.. (1994). Thymus‐leukaemia antigens: The haemochromatosis gene product?. Immunology and Cell Biology. 72(5). 435–439. 6 indexed citations
19.
Dorak, M. Tevfik, Elizabeth Chalmers, Dairena Gaffney, et al.. (1994). Human Major Histocompatibility Complex Contains Several Leukemia Susceptibility Genes. Leukemia & lymphoma. 12(3-4). 211–222. 39 indexed citations
20.
Worwood, Mark, Ruma Raha‐Chowdhury, M. Tevfik Dorak, et al.. (1994). Alleles at D6S265 and D6S105 define a haemochromatosis‐specific genotype. British Journal of Haematology. 86(4). 863–866. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew A. Adjei Breakdown of academic impact, for papers by Thomas Stallmach Breakdown of academic impact, for papers by G.M.P. Galbraith Breakdown of academic impact, for papers by Peter G. Middleton Breakdown of academic impact, for papers by Judith A. Smith Breakdown of academic impact, for papers by Simone Kashima Breakdown of academic impact, for papers by R. Clark Brown Breakdown of academic impact, for papers by Issarang Nuchprayoon Breakdown of academic impact, for papers by C Cooper Breakdown of academic impact, for papers by Maurice R.G. O’Gorman
Rankless by CCL
2026